Javelin Pharmaceuticals Launches Dyloject(R) in UK

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (AMEX:JAV) today announced that it has received and published its UK pricing for Dyloject® (diclofenac sodium solution for injection). Pricing was received from the Department of Health Pharmaceutical Price Regulation Scheme (“PPRS”). PPRS accepted Javelin’s proposal that the National Health Service (NHS) Tariff Price for Dyloject be GBP 48.00 per pack (10 x 75mg/2ml vials).

MORE ON THIS TOPIC